Press Releases

Flagship Pioneering and its portfolio companies make news because of their transformative approaches to solving global challenges. If you have needs beyond these resources, please contact press@flagshippioneering.com.

company

year

domain

Flagship Pioneering Bolsters Executive Team with Appointment of Fabrice Chouraqui in Newly Created Dual Role of Flagship CEO-Partner and CEO of Cellarity

Cellarity 05.28.2020

Flagship Pioneering Unveils Latest Company: Invaio Sciences

05.27.2020

Moderna Announces Positive Interim Phase 1 Data for its mRNA Vaccine (mRNA-1273) Against Novel Coronavirus

Moderna 05.18.2020

Repertoire Immune Medicines Strengthens Executive Team; Names Biotech Industry Veterans to Key Roles

Repertoire Immune Medicines 04.23.2020

Cygnal Therapeutics Leader and Scientific Advisory Board Members Co-Author Paper in Cell Alongside Cancer Science Experts

Cygnal Therapeutics 04.16.2020

CIBO Launches Land Intelligence Platform

CiBO Technologies 04.06.2020

Flagship Pioneering Completes Raising a New $1.1 Billion Capital Pool

Flagship Pioneering 04.02.2020

Repertoire Immune Medicines Launches Type 1 Diabetes Focused Program with Investment from JDRF T1D Fund

Repertoire Immune Medicines 03.25.2020

Seres Therapeutics Appoints Paul Biondi, Experienced Biopharmaceutical Strategy and Corporate Development Professional, to Its Board of Directors

Seres Therapeutics 03.23.2020

Flagship Pioneering Announces the Launch of Repertoire Immune Medicines with Industry Veteran John G. Cox as Chief Executive Officer

Repertoire Immune Medicines 03.12.2020

Loading